Sign in

CIK 0000887359 · Large accelerated filer

Vericel Corp

Sign in to watch
Ticker
VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
MI
Entity type
operating
EIN
943096597
Phone
6175885555
Business address
25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
Former names
AASTROM BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,787,802
in 7 filings, $5.8M under 10b5-1 plans

Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-11-23 ZERBE ROBERT L MD Director Option exercise · Stock Option (right to buy) −15,000 0
2020-06-23 Halpin Michael Chief Operating Officer Option exercise +14,751 $7.20 $106K 16,373
2020-06-23 Halpin Michael Chief Operating Officer Sale −14,751 $15.01 $221K 1,622
2020-06-23 Halpin Michael Chief Operating Officer Option exercise · Stock Option (right to buy) −14,751 20,579
2020-06-16 Halpin Michael Chief Operating Officer Option exercise +2,890 $2.65 $8K 5,624
2020-06-16 Halpin Michael Chief Operating Officer Sale −2,890 $15.00 $43K 2,734
2020-06-16 Halpin Michael Chief Operating Officer Sale −1,112 $15.00 $17K 1,622
2020-06-16 Halpin Michael Chief Operating Officer Option exercise · Stock Option (right to buy) −2,890 77,063
2020-05-08 Colangelo Dominick President and CEO Option exercise +13,125 $2.75 $36K 210,492
2020-05-08 Colangelo Dominick President and CEO Option exercise · Stock Option (right to buy) −13,125 65,625
2020-04-29 ZERBE ROBERT L MD Director Option exercise +1,750 19,295
2020-04-29 ZERBE ROBERT L MD Director Option exercise · Restricted Stock Unit −1,750 0
2020-04-29 ZERBE ROBERT L MD Director Grant or award · Restricted Stock Unit +1,750 1,750
2020-04-29 ZERBE ROBERT L MD Director Grant or award · Stock Option (right to buy) +13,125 13,125
2020-04-29 GILMAN STEVEN C Director Option exercise +1,750 1,750
2020-04-29 GILMAN STEVEN C Director Option exercise · Restricted Stock Unit −1,750 $14.56 $25K 0
2020-04-29 GILMAN STEVEN C Director Grant or award · Stock Option (right to buy) +13,125 13,125
2020-04-29 GILMAN STEVEN C Director Grant or award · Restricted Stock Unit +1,750 1,750
2020-04-29 Hagen Heidi Director Option exercise +1,750 1,750
2020-04-29 Hagen Heidi Director Option exercise · Restricted Stock Unit −1,750 $14.56 $25K 0

Page 54 of 75 · 1,497 trades